Copyright
©The Author(s) 2026.
World J Diabetes. Feb 15, 2026; 17(2): 114124
Published online Feb 15, 2026. doi: 10.4239/wjd.v17.i2.114124
Published online Feb 15, 2026. doi: 10.4239/wjd.v17.i2.114124
| No. | Citation | Year | Country | Design | Gut microbiota assessed | Circulating cfDNA assessed | Sequencing Methodology | Contamination controls | Antibiotics reported/controlled | Longitudinal | Key findings | Limitations |
| 1 | Gomez-Arango et al[55] | 2016 | Australia | Cross-sectional; overweight/obese pregnant women; n = 70 | Yes (fecal 16S) | No | 16S rRNA (Illumina) | Not reported | Not reported | No | Collinsella associated with insulin; gut taxa correlate with metabolic hormones | Small sample, overweight/obese cohort, no cfDNA data |
| 2 | Crusell et al[4] | 2018 | Denmark | Case-control and longitudinal postpartum; GDM n = 50, controls n = 157 | Yes (fecal 16S + metagenomics) | No | 16S rRNA/shotgun (variable) | Not clearly stated | Not reported | Yes (postpartum) | GDM associated with altered fecal microbiota (Collinsella, Rothia, Desulfovibrio) | Heterogeneous methods, observational |
| 3 | Ferrocino et al[56] | 2018 | Italy | Prospective observational; GDM n = 41, controls | Yes (fecal 16S) | No | 16S rRNA | Not reported | Not reported | Yes (pregnancy) | Microbiota changes during pregnancy in GDM; links to diet and metabolic markers | Small sample, observational |
| 4 | Pinto et al[57] | 2023 | United Kingdom/Israel (multi-centre) | Prospective cohort; early sampling before GDM diagnosis; sizeable cohort (development and validation) | Yes (multi-omics fecal) | No | 16S/shotgun metagenomics, metabolomics | Reported (standard pipelines) | Partially reported | Yes (samples months before diagnosis) | Microbiota-induced inflammation precedes GDM; decreased fecal SCFAs in those who developed GDM | Requires mechanistic validation |
| 5 | Hu et al[58] | 2021 | China | Prospective cohort; early pregnancy sampling; moderate N | Yes | No | 16S rRNA | Not reported | Not reported | Yes | Early pregnancy gut microbiota associated with later GDM risk | Needs replication in other populations |
| 6 | Witt et al[59] | 2020 | United States | Case-control; chorioamnionitis cases vs controls; small N | No | Yes (mcfDNA sequencing in maternal plasma) | Shotgun cfDNA sequencing (NGS) | Described (negative controls) | Not central to study | No | mcfDNA detected in maternal and cord plasma in chorioamnionitis; higher levels vs controls | Not GDM-focused; small sample |
| 7 | Tang et al[60] | 2024 | China/International | Longitudinal cfDNA study; GDM n = 299, controls n = 299 | Partially (integrative analyses) | Yes (deep cfDNA sequencing) | High-depth cfDNA sequencing (Illumina) | Reported (bioinformatic filters) | Not fully reported | Yes | cfDNA fragment features associated with GDM across pregnancy; potential predictive signals | Needs external replication; novel methods |
| 8 | Wang et al[61] | 2023 | China | Large cohort (n > 5000), cfDNA sequencing data for GDM prediction | No | Yes (cfDNA features) | NIPT-style cfDNA sequencing | Not fully described in abstract | Not reported | No (screening dataset) | Machine learning on cfDNA can screen/predict GDM | Early; requires independent validation and contamination-aware analysis |
| 9 | Su et al[62] | 2021 | China | Case-control; GDM vs controls; small N | Yes (fecal 16S) | No | 16S rRNA | Not reported | Not reported | No | Distinct gut microbiota signatures in GDM | Cross-sectional; small sample |
| 10 | Liu et al[63] | 2019 | China | Case-control/prospective; moderate N | Yes (fecal metagenomics) | No | Shotgun metagenomics | Not reported | Not reported | Some follow-up | Fecal microbiota linked to plasma lipidome and GDM risk | Causality not established |
| 11 | Zheng et al[64] | 2020 | China | Prospective; first half of pregnancy; sample size moderate | Yes (16S) | No | 16S rRNA | Not reported | Not reported | Yes | Reduced dynamics of gut microbiota during early pregnancy associated with GDM | Population-specific; replication needed |
| 12 | Ma et al[65] | 2020 | China | Cross-sectional; first trimester | Yes | No | 16S rRNA | Not reported | Not reported | No | Altered early pregnancy microbiota in GDM patients | Small; cross-sectional |
| 13 | Ponzo et al[66] | 2019 | Italy | Associated with Ferrocino dataset; maternal and offspring microbiome studies | Yes | No | 16S rRNA | Not reported | Not reported | Yes (infant follow-up) | Offspring microbiota influenced by maternal GDM | Cohort-specific |
- Citation: Vasudevan D. Gut microbiota dysbiosis, circulating microbial genetic traces, and their role in gestational diabetes. World J Diabetes 2026; 17(2): 114124
- URL: https://www.wjgnet.com/1948-9358/full/v17/i2/114124.htm
- DOI: https://dx.doi.org/10.4239/wjd.v17.i2.114124
